Overwhelming neutrophil-mediated inflammation, secondary to infection, has been demonstrated in severe human sepsis,32 whereas a beneficial effect of the PAD inhibitor Cl-amidine has been demonstrated in an LPS-induced mouse model of sepsis.33 Therefore, we decided to include an LPS-induced sepsis mouse model in our preclinical basket approach. Here, PADI4 is linked to infection.